Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|17|6|802-812

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.17, Iss.6, 2017-06, pp. : 802-812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 304-310

Spandidos Publications

Access to resources Recommend Favorite

Preclinical Studies of a New Generation Retroviral Vector for Ovarian Cancer BRCA1 Gene Therapy

By Tait D.L.   Obermiller P.S.   Holt J.T.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 471-476

Elsevier

Access to resources Recommend Favorite

New Approaches for the Prevention of Bone Metastases in Patients with Prostate Cancer: A Review of Preclinical and Clinical Studies

By Lassiter L.K.   Carducci M.A.  

American Journal of Cancer, Vol. 2, Iss. 3, 2003-01 ,pp. : 181-199

Adis International

Access to resources Recommend Favorite

Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application

By Bergs J. W. J.   Franken N. A. P.   Haveman J.   Geijsen E. D.   Crezee J.   van Bree C.  

International Journal of Hyperthermia, Vol. 23, Iss. 4, 2007-01 ,pp. : 329-341

Informa Healthcare

Access to resources Recommend Favorite

Pion and Heavy Ion Radiotherapy: Pre-Clinical and Clinical Studies

By Fowler J.F.  

International Journal of Radiation Biology, Vol. 44, Iss. 5, 1983-11 ,pp. : 534-534

Informa Healthcare

Access to resources Recommend Favorite